United States· US:70842-120_163f9a07-823d-4c53-9136-8783e95f9cdc
VABOMERE
A meropenem and vaborbactam product containing vaborbactam; meropenem, registered in United States by Melinta Therapeutics, LLC. The same ATC class is registered in 13 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Meropenem and vaborbactam is registered in 13 of 19 countries.
Countries holding a registration under ATC J01DH52 (meropenem and vaborbactam), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Meropenem and vaborbactam · ATC J01DH52
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- VABORBACTAM; MEROPENEM
- Manufacturer
- Melinta Therapeutics, LLC
- Country
- United States (US)
- ATC code
- J01DH52
- ATC class
- Meropenem and vaborbactam
- Defined daily dose
- 3 g, P
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1170842120066 VIAL, SINGLE-DOSE in 1 CARTON (70842-120-06) / 2 g in 1 VIAL, SINGLE-DOSE (70842-120-01)
- ndc1170842-120-06
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Meropenem and vaborbactam in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandVaborem 1g/1g, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungA. Menarini GmbH
- CzechiaVABOREMMenarini International Operations Luxembourg S.A., Luxembourg
- SpainVABOREM 1 G/1 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONMenarini International Operations Luxembourg S.A.
- FinlandVaboremMenarini International Operations Luxembourg S.A.
- FranceVABOREM 1 g/1 g, poudre pour solution à diluer pour perfusionMENARINI INTERNATIONAL OPERATIONS LUXEMBOURG
- United KingdomVaborem 1g/1g powder for concentrate for solution for infusion vialsA. Menarini Farmaceutica Internazionale SRL
- IrelandVaborem 1 g/1 g powder for concentrate for solution for infusionMenarini International Operations Luxembourg S.A.
- IcelandVaboremMenarini International Operations Luxembourg S.A.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vaborem
- Liechtenstein · Vaborem
- Norway · Vaborem
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9c2ea749-98c9-455c-85c4-dc4f6855b3a0 GET /v1/drugs/9c2ea749-98c9-455c-85c4-dc4f6855b3a0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "1; 1",
"substance": "VABORBACTAM; MEROPENEM",
"productndc": "70842-120",
"dosage_form": "INJECTION, POWDER, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "g/2g; g/2g",
"application_number": "NDA209776",
"marketing_category": "NDA"
}See everything about meropenem and vaborbactam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.